✦ LIBER ✦

A phase IV randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of efalizumab in patients with moderate to severe plaque psoriasis involving the scalp

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Moderate to severe plaque psoriasis with

✍ Jerry Bagel; Charles Lynde; Stephen Tyring; Gregory Kricorian; Yifei Shi; Paul K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Patient-reported outcomes in moderate-to

✍ S. Tyring; J. Bagel; C. Lynde; P. Klekotka; E.H.Z. Thompson; S.R. Gandra; Y. Shi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Safety of efalizumab in adults with chro

✍ Kim A. Papp; Reni Bressinck; Scott Fretzin; Bernard Goffe; Steven Kempers; Kenne 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

A randomized, double-blind, placebo-cont

✍ A.B. Gottlieb; R.G. Langley; B.E. Strober; K.A. Papp; P. Klekotka; K. Creamer; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Efficacy and safety of efalizumab in pat

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Efficacy of efalizumab in the treatment

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB